CLINIC AND MANAGEMENT OF ERYTHEMATO-DESCAMMATIVE DERMATOSIS IN PEOPLE LIVING WITH HIV (PLHIV)

Abstract

Introduction: Erythematous squamous cell dermatosis is a type of skin disease characterized by erythema and scaling, often associated with immunocompromising conditions, including HIV infection. Objective: To analyze the existing knowledge on the clinical and management of erythematous squamous cell dermatoses in PLHIV. Method: An integrative review of the literature was conducted, which included research published between 2020 and 2024. Results: The review revealed that PLHIV have a higher prevalence of dermatoses such as seborrheic dermatitis, psoriasis and pityriasis versicolor, which are more intense and recurrent compared to the general population. The management of these dermatoses varies according to the level of immunosuppression and the response to antiretroviral treatment (ART). Conclusion: PLHIV are particularly vulnerable to erythematous squamous cell dermatoses due to their compromised immunological status, requiring adapted dermatological and therapeutic interventions.